Charing Cross Hospital

Comparing Functional (PET) Images: The Assessment of Significant Change

Statistical parametric maps (SPMs) are potentially powerful ways of localizing differences in regional cerebral activity. This potential is limited by uncertainties in assessing...

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial

The Relationship between Global and Local Changes in PET Scans

In order to localize cerebral cognitive or sensorimotor function, activation paradigms are being used in conjunction with PET measures of cerebral activity (e.g., rCBF). The cha...

Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials

Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy

Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial

Cloning of the essential myotonic dystrophy region and mapping of the putative defect

THE LEFT MEDIAL TEMPORAL REGION AND SCHIZOPHRENIA: A PET STUDY

Regional cerebral blood flow (rCBF) was measured in 30 schizophrenic patients with severe, persistent and stable symptoms using positron emission tomography (PET). Directed and ...

Regional response differences within the human auditory cortex when listening to words

INTRAUTERINE DEVICE: POSSIBLE ROLE OF PROSTAGLANDINS